Natural Albumin Market Opportunities & Forecast to 2031

The natural albumin market size is projected to reach US$ 8.46 billion by 2031 from US$ 5.66 billion in 2024. The market is expected to register a CAGR of 6.0% during 2025–2031.          

Natural​‍​‌‍​‍‌​‍​‌‍​‍‌ albumin is a water-soluble protein and is the major constituent of blood plasma in humans and animals. It helps to maintain oncotic pressure, transport hormones, vitamins, and drugs, and regulate the fluid balance in the body. It is a pure protein extracted from human serum or an animal source. Natural albumin is a rescue agent in conditions such as hypoalbuminemia, shock, burns, and liver diseases. It is minimally immune-reactive, highly biologically compatible, and strongly biologically functional, which makes it indispensable in therapeutics, diagnostics, and cell culture media. However, issues such as infectious agent transmission and supply shortages have prompted a shift in the demand for safer recombinant products that maintain quality control ​‍​‌‍​‍‌​‍​‌‍​‍‌standards.

Natural Albumin Market Analysis

Natural albumin is mainly derived from human plasma and is preferred to treat hypovolemia, burns, and liver diseases. Its demand is primarily driven by its long-standing clinical efficacy and easy availability. The market growth is restrained by issues such as pathogen transmission, supply shortages, and variations in product quality. Despite improved purification methods for safety, sourcing issues and the risk of viral contamination persist. The market is also affected by competition from other recombinant alternatives that have better safety profiles and are scalable.  

Natural Albumin Market Overview  

Natural Albumin is becoming increasingly popular due to the growing number of patients being treated with plasma-derived therapies (PDTs). The continued use of Natural Albumin in the fields of critical care and the treatment of Liver illnesses, in addition to its support for fluid resuscitation and as a Component in Drug Formulations, will ensure that Natural Albumin remains relevant in both the hospital and scientific communities. Together, these market drivers support the continued growth of the market due to the development of more efficient systems for blood-plasma collection, as well as technological advancements to provide methods for improved purification of protein materials. In addition, increased awareness of the many therapeutic and stabilizing properties of albumin, as well as a growing need to find dependable biologics, has resulted in an increase in the acceptance of Natural Albumin as an essential component within the global Healthcare and Life-Science industries.        

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Natural Albumin Market: Strategic Insights

Natural Albumin Market Drivers and Opportunities

Market Drivers:

• Established Clinical Efficacy: For a long time, natural albumin has been effective in the treatment of various kinds of severe conditions such as liver disease, burns, and shock, thus it is considered a safe and easily accepted therapeutic option.
• Broad Availability and Familiarity: The widespread availability of the product across healthcare systems worldwide, along with familiarity among medical professionals, ensures its steady market presence and continued use.

Market Opportunities:

• Expanding Indications: Research into new therapeutic applications for natural albumin could drive additional demand beyond its current established uses.
• Emerging Market Growth: Expanding healthcare infrastructure and improving access in developing regions create opportunities for wider adoption of natural albumin.

Natural Albumin Market Report Segmentation Analysis

The natural albumin market is divided into different segments to give a clearer view of how it works, its growth potential, and the latest trends. Below is the standard segmentation approach used in industry reports:

By Source:

• Human Serum Albumin: The human serum albumin (HSA) segment is growing due to its extensive clinical use in treating hypoalbuminemia, shock, burns, and liver diseases. Its high biocompatibility, established safety profile, and wide acceptance in therapeutics, diagnostics, and drug formulation drive consistent demand.    
• Bovine Serum Albumin: The bovine serum albumin (BSA) segment is growing due to its widespread use in research, diagnostics, and biopharmaceutical applications. Its affordability, availability, and stability make it ideal for laboratory assays, cell culture, and drug formulation.   
• Plant Serum Albumin: The plant serum albumin (PSA) segment is growing due to rising demand for animal-free, sustainable, and ethically sourced albumin. Its use in therapeutics, diagnostics, and research applications offers safety advantages, reduces contamination risks, and aligns with regulatory preferences.   

By Application:

• Therapeutic Applications: The therapeutic applications segment is growing as natural albumin is essential for treating hypoalbuminemia, shock, burns, and liver or kidney diseases. Its proven efficacy, safety, and biocompatibility make it a critical component in clinical care.
• Drug Delivery: The drug delivery segment is growing because natural albumin acts as a reliable carrier for drugs, enhancing stability, solubility, and targeted delivery. Its biocompatibility and ability to bind therapeutic molecules make it valuable in formulations, driving increased adoption in pharmaceuticals.
• Disease Diagnostics: The disease diagnostics segment is growing as natural albumin is widely used as a stabilizer and reagent in diagnostic assays. Its consistency, purity, and compatibility with various biomarkers improve test accuracy and reliability, driving demand in clinical laboratories and research.
• Research: The research segment is growing as natural albumin is extensively used in laboratories for cell culture, protein stabilization, and biochemical assays. Its reliability, purity, and availability make it essential for experimental reproducibility, driving higher adoption in academic and industrial research.
• Others: The others segment is growing due to the use of natural albumin in food processing, cosmetics, and industrial biotechnology. Its functional properties, such as emulsification, stabilization, and binding capacity, create diverse applications beyond healthcare and research.

By End User:

• Hospitals and Clinics
• Pharmaceutical and Biotechnological Companies
• Research Institutes
• Diagnostic Laboratories
• Homecare Settings
• Others

By Geography:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Natural Albumin Market Regional Insights

The regional trends and factors influencing the Natural Albumin Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Natural Albumin Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Natural Albumin Market Report Scope

Natural Albumin Market Players Density: Understanding Its Impact on Business Dynamics

The Natural Albumin Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Natural Albumin Market Share Analysis by Geography

North America leads the natural albumin market, primarily because of an established healthcare infrastructure, broad use of albumin in critical care, surgical, and emergency settings, and extensive networks for plasma donation and fractionation. The strong presence of major hospitals, high healthcare spending, and widespread use in therapeutic, diagnostic, and biopharmaceutical applications reinforces natural albumin’s central role in global demand.

Europe has a well-matured healthcare system, robust regulatory framework, and high plasma fractionation capacities. There is a consistent demand for albumin across hospitals, diagnostics, and research settings. Several European countries rely on plasma-derived albumin for treating liver-, kidney-, or trauma-related conditions, which sustains stable demand.

The market in Asia Pacific is led by countries such as China and India. Rapidly expanding healthcare infrastructure, rising chronic disease incidence, increasing surgical and trauma care needs, and the growth of biopharmaceutical manufacturing collectively drive the adoption of plasma-derived albumin. As hospitals and critical care facilities become more accessible, demand from therapeutic, diagnostic, and general care segments is on the rise.

The market in regions such as Middle East & Africa and South & Central America is growing at a modest pace. Growth factors include improving healthcare infrastructure, increasing access to plasma-derived therapies, and expanding hospital networks. As these regions continue advancing medical capacity and access, their share in global albumin consumption is expected to grow.

The market growth varies across regions due to factors such as an aging population and an increasing prevalence of mobility-related disorders. Below is a summary of market share and trends by region:

1. North America

• Market Share: Holds a significant portion of the global market
• Key Drivers:
  • Rising demand for volume expansion in critical care and sepsis management
  • Increasing hypoalbuminemia in chronic liver disease
•  Trends: Growing preference for recombinant albumin as an alternative

2. Europe

• Market Share: Holds a substantial market share
• Key Drivers:
  • High prevalence of chronic conditions and an aging population
  • Robust healthcare infrastructure and favorable regulatory compliance
• Trends: Increasing focus on local plasma sourcing and regulatory shifts.

3. Asia Pacific

• Market Share: Fastest-growing region with an annually rising market share
• Key Drivers:
  • Rapidly expanding healthcare infrastructure and patient access
  • Growing burden of liver and critical illnesses
• Trends: Strategic push for domestic plasma fractionation and self-sufficiency.

4. South and Central America

• Market Share: Growing market with steady progress
• Key Drivers:
  • Growing demand from public health systems
  • High unmet need and expanding patient base for chronic diseases
• Trends: Significant dependence on imports and price volatility.

5. Middle East and Africa

• Market Share: Holds a small market share, growing at a rapid pace
• Key Drivers:
  • Significant healthcare infrastructure investment in the Middle East
  • Rising prevalence of lifestyle-related and infectious diseases
• Trends: Acute Rapid Growth of Cell Culture Supplements

Natural Albumin Market Players Density: Understanding Its Impact on Business Dynamics

High Market Density and Competition

The market is highly competitive due to the presence of established players such as CSL Ltd and Grifols SA.  Niche providers also contribute to the competitive landscape across regions.

This high level of competition urges companies to stand out by offering:

• Advanced products
• Value-added services such as customization and sustainable solutions
• Competitive pricing models
• Compliance with regulatory guidelines

Opportunities and Strategic Moves

• Growing demand for safer, virus-free alternatives to plasma-derived products offers significant market entry and expansion for recombinant platforms. Healthgen Biotechnology gained approval in China for its rice-derived recombinant human albumin, showcasing platform diversification.
• Albumin's natural carrier properties, biocompatibility, and tumor-targeting ability create an opportunity for novel nanoparticle-based drug therapies. Apotex Corp. launched a generic albumin-bound Paclitaxel for injection, leveraging albumin's role for improved drug delivery in oncology.
• The rapid expansion of healthcare infrastructure and rising chronic disease prevalence in Asia Pacific drive demand and create new regional revenue streams. Kedrion Biopharma expanded its human serum albumin portfolio into the Chinese market to enhance treatment options and strengthen its global footprint.

Major Companies operating in the Natural Albumin Market are:

1. CSL Ltd             
2. Merck KGaA                 
3. HiMedia Laboratories Pvt Ltd              
4. Thermo Fisher Scientific Inc     
5. InVitria              
6. Medxbio Pte Ltd            
7. Lazuline Biotech Private Limited
8. Cyagen Biosciences       
9. Sartorius AG                 
10. Akron Biotech

Disclaimer: The companies listed above are not ranked in any particular order.

Other companies analyzed during the course of research:

1. Albumedix Ltd.
2. Ventria Bioscience
3. Novozymes A/S
4. Oryzogen Biopharmaceuticals
5. NCPC Genetech Biotechnology
6. ProSpec-Tany TechnoGene Ltd.
7. Recombinant Technologies Inc.
8. Dyadic International, Inc.
9. ACROBiosystems
10. Sino Biological Inc.

Natural Albumin Market News and Recent Developments

• Dyadic and Proliant Collaborate to Develop Animal-Free Recombinant Albumin in June 2024. Dyadic signed a development and commercialization agreement with Proliant to produce animal‑free recombinant human serum albumin (rHSA) using Dyadic’s microbial platform, marking a major step toward non‑plasma albumin supply.
• InVitria Launches Optibumin 25 for Biomanufacturing in February 2025. InVitria Launched Optibumin 25, a 25 % recombinant human serum albumin solution designed for closed-system biomanufacturing in cell and gene therapy, offering a chemically defined, animal-origin-free alternative.   

Natural Albumin Market Report Coverage and Deliverables

The "Natural Albumin Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

• Natural Albumin Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Natural Albumin Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST and SWOT analysis
• Natural Albumin Market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the natural albumin Market
• Detailed company profiles